Paramount BioCapital Asset Management logo

Paramount BioCapital Asset Management

North America, New York, United States, New York

Description

Paramount BioSciences is a global pharmaceutical development and healthcare investment firm that conceives, nurtures, and supports new

Investor Profile

Paramount BioCapital Asset Management has backed more than 5 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 20% of its total and boasts 5 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity, Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.

Stage Focus

  • Post Ipo Equity (60%)
  • Series Unknown (40%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Therapeutics
  • Medical
  • Biopharma
  • Genetics
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Paramount BioCapital Asset Management frequently co-invest with?

Iroquois Capital
North America, Tennessee, United States, Nashville
Co-Investments: 1
WC
North America, Ontario, Canada, Toronto
Co-Investments: 1
MB
North America, New York, United States, New York
Co-Investments: 1
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
Alpha Capital
North America, Illinois, United States, Chicago
Co-Investments: 1
RC
North America, New York, United States, New York
Co-Investments: 1
Midsummer Capital
North America, New York, United States, New York
Co-Investments: 1
FM
North America, California, United States, San Francisco
Co-Investments: 1
ArmaVir Partners
North America, New York, United States, New York
Co-Investments: 1
CA
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by Paramount BioCapital Asset Management?

CEL-SCI

Vienna, Virginia, United States

CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.

BiotechnologyHealth CareMedical
Post Ipo EquityAug 20, 2009
Amount Raised: $4,400,000
Innovive Pharmaceuticals

New York, New York, United States

Innovive Pharmaceuticals is a development stage company.

BiotechnologyHealth CarePharmaceutical
Series UnknownApr 25, 2007
Amount Raised: $15,000,000
Genelabs Technologies

Redwood City, California, United States

Genelabs Technologies is a biopharmaceutical company engaged in the R&D of therapeutics for the treatment of infectious diseases.

BiopharmaBiotechnologyHealth CareTherapeutics
Series UnknownJun 27, 2006
Amount Raised: $8,300,000
Alaunos Therapeutics

New York, New York, United States

Alaunos Therapeutics is a biotechnology company that acquires, develops, and commercializes cancer therapies.

BiotechnologyGeneticsOncologyPharmaceuticalTherapeutics
Post Ipo EquityMay 3, 2006
Amount Raised: $37,000,000
Chelsea Therapeutics International

Charlotte, North Carolina, United States

Chelsea Therapeutics International is a pharmaceutical company developing and commercializing therapeutics for a variety of human diseases.

BiotechnologyHealth CarePharmaceutical
Post Ipo EquityJan 12, 2005
Amount Raised: $14,500,000

Find More Investors Like Paramount BioCapital Asset Management

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Paramount BioCapital Asset Management | Pipeseed